GlassScriptPhysician profile
Micheal J Freeman
NPI 1639112261
$2,442.96
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $758 · 2020: $307 · 2021: $354 · 2022: $771 · 2023: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $687.36 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $514.59 | 2019-2023 | Dupixent |
| Janssen Biotech, INC. | $284.24 | 2019-2022 | |
| Pfizer INC. | $216.40 | 2019-2023 | |
| Janssen Scientific Affairs, LLC | $137.55 | 2022 | |
| Almirall LLC | $95.30 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $80.47 | 2023 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $56.05 | 2019-2020 | |
| Organogenesis INC. | $47.74 | 2020-2023 | Puraply |
| Genentech USA, INC. | $47.72 | 2019 | |
| Amgen INC. | $45.11 | 2019-2020 | |
| Dusa Pharmaceuticals, INC. | $42.95 | 2019 | |
| Sensus Healthcare, INC. | $42.60 | 2021 | |
| Dendreon Pharmaceuticals LLC | $33.79 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $21.03 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $19.95 | 2021 | |
| Leo Pharma INC. | $18.23 | 2023 | Adbry |
| Nabriva Therapeutics, Plc | $14.27 | 2021 | |
| Vyne Pharmaceuticals INC. | $13.60 | 2020 | |
| Genzyme Corporation | $13.15 | 2022 | |
| Strata Skin Sciences, INC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micheal Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.